Jennifer Sue Pitrak Mcdonald

Array ( [id] => 4873927 [patent_doc_number] => 20080200661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-21 [patent_title] => 'COMPOSITION FOR IN VIVO DELIVERY' [patent_app_type] => utility [patent_app_number] => 11/756808 [patent_app_country] => US [patent_app_date] => 2007-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18619 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0200/20080200661.pdf [firstpage_image] =>[orig_patent_app_number] => 11756808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6441651 [patent_doc_number] => 20100104581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'Methods for Diagnosing and Treating Graft Rejection and Inflammatory Conditions' [patent_app_type] => utility [patent_app_number] => 12/302089 [patent_app_country] => US [patent_app_date] => 2007-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5321 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20100104581.pdf [firstpage_image] =>[orig_patent_app_number] => 12302089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5028445 [patent_doc_number] => 20070269892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'FORMULATIONS FOR INTRACELLULAR DELIVERY dsRNA' [patent_app_type] => utility [patent_app_number] => 11/750979 [patent_app_country] => US [patent_app_date] => 2007-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 23302 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20070269892.pdf [firstpage_image] =>[orig_patent_app_number] => 11750979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024371 [patent_doc_number] => 20110052697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'Aptamer-Directed Drug Delivery' [patent_app_type] => utility [patent_app_number] => 12/301225 [patent_app_country] => US [patent_app_date] => 2007-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 46635 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052697.pdf [firstpage_image] =>[orig_patent_app_number] => 12301225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5443070 [patent_doc_number] => 20090094709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'Use of protein phosphatase 2Ce (PP2Ce) having dephosphorylating action on AMPK' [patent_app_type] => utility [patent_app_number] => 11/798774 [patent_app_country] => US [patent_app_date] => 2007-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8985 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20090094709.pdf [firstpage_image] =>[orig_patent_app_number] => 11798774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5496475 [patent_doc_number] => 20090264503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'SHORT INTERFERENCE RIBONUCLEIC ACIDS FOR TREATING ALLERGIC DISEASES' [patent_app_type] => utility [patent_app_number] => 12/300337 [patent_app_country] => US [patent_app_date] => 2007-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 9822 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264503.pdf [firstpage_image] =>[orig_patent_app_number] => 12300337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5521951 [patent_doc_number] => 20090029932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'Identification and use of miRNAs for differentiating myeloid leukemia cells' [patent_app_type] => utility [patent_app_number] => 11/800044 [patent_app_country] => US [patent_app_date] => 2007-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8632 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20090029932.pdf [firstpage_image] =>[orig_patent_app_number] => 11800044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5349970 [patent_doc_number] => 20090005331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'AChE antisense oligonucleotide as an anti-inflammatory agent' [patent_app_type] => utility [patent_app_number] => 11/788321 [patent_app_country] => US [patent_app_date] => 2007-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 21920 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20090005331.pdf [firstpage_image] =>[orig_patent_app_number] => 11788321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5259889 [patent_doc_number] => 20070213521 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'siRNA targeting cell division cycle 25 (CDC25C)' [patent_app_type] => utility [patent_app_number] => 11/784752 [patent_app_country] => US [patent_app_date] => 2007-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 34785 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20070213521.pdf [firstpage_image] =>[orig_patent_app_number] => 11784752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8713282 [patent_doc_number] => 08399422 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-19 [patent_title] => 'Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications' [patent_app_type] => utility [patent_app_number] => 12/226027 [patent_app_country] => US [patent_app_date] => 2007-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 15568 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12226027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5225779 [patent_doc_number] => 20070255046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'siRNA targeting spectrin SH3 domain binding protein 1 (SSH3BP1)' [patent_app_type] => utility [patent_app_number] => 11/732809 [patent_app_country] => US [patent_app_date] => 2007-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 34922 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20070255046.pdf [firstpage_image] =>[orig_patent_app_number] => 11732809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5159418 [patent_doc_number] => 20070172462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'siRNA-mediated gene silencing of synuclein' [patent_app_type] => utility [patent_app_number] => 11/726211 [patent_app_country] => US [patent_app_date] => 2007-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14965 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20070172462.pdf [firstpage_image] =>[orig_patent_app_number] => 11726211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4949888 [patent_doc_number] => 20080306014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial' [patent_app_type] => utility [patent_app_number] => 11/714861 [patent_app_country] => US [patent_app_date] => 2007-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 45120 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20080306014.pdf [firstpage_image] =>[orig_patent_app_number] => 11714861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6499932 [patent_doc_number] => 20100286232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'MICRORNA EXPRESSION PROFILE ASSOCIATED WITH PANCREATIC CANCER' [patent_app_type] => utility [patent_app_number] => 12/281194 [patent_app_country] => US [patent_app_date] => 2007-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 21414 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286232.pdf [firstpage_image] =>[orig_patent_app_number] => 12281194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4651022 [patent_doc_number] => 20080038278 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'GPAT3 encodes a mammalian, microsomal acyl-coa:glycerol 3- phosphate acyltransferase' [patent_app_type] => utility [patent_app_number] => 11/711577 [patent_app_country] => US [patent_app_date] => 2007-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 22185 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20080038278.pdf [firstpage_image] =>[orig_patent_app_number] => 11711577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5159423 [patent_doc_number] => 20070172467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'Regeneration of endogenous myocardial tissue by induction of neovascularization' [patent_app_type] => utility [patent_app_number] => 11/648769 [patent_app_country] => US [patent_app_date] => 2006-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 26849 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20070172467.pdf [firstpage_image] =>[orig_patent_app_number] => 11648769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4650989 [patent_doc_number] => 20080038245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Methods of modulating angiogenesis' [patent_app_type] => utility [patent_app_number] => 11/646933 [patent_app_country] => US [patent_app_date] => 2006-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23521 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20080038245.pdf [firstpage_image] =>[orig_patent_app_number] => 11646933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5502209 [patent_doc_number] => 20090162897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'Promoter Sequences' [patent_app_type] => utility [patent_app_number] => 12/097799 [patent_app_country] => US [patent_app_date] => 2006-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13117 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162897.pdf [firstpage_image] =>[orig_patent_app_number] => 12097799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5453225 [patent_doc_number] => 20090069262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Cationic Oligonucleotides, Automated Methods for Preparing Same and Their Uses' [patent_app_type] => utility [patent_app_number] => 12/086599 [patent_app_country] => US [patent_app_date] => 2006-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 7153 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20090069262.pdf [firstpage_image] =>[orig_patent_app_number] => 12086599 [rel_patent_id] =>[rel_patent_doc_number] =>)